Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-25 @ 11:57 AM
NCT ID:
NCT02588261
Group ID:
EG001
Title:
Erlotinib or Gefitinib
Description:
Participants received 150 mg of erlotinib or 250 mg of gefitinib orally once daily in 28-day cycles until one of the discontinuation criteria was met (developed radiological progressive disease, required to receive local or systemic anti-cancer treatment, developed unacceptable toxicity, participant pregnancy, investigator decision, required to receive significant surgical procedure, participant protocol deviation or noncompliance, participant decline of further treatment and participant lost to follow-up).
Deaths Number Affected:
35
Deaths Number At Risk:
None
Serious Number Affected:
67
Serious Number At Risk:
262
Other Number Affected:
253
Other Number At Risk:
262
Study:
NCT02588261
Results Section:
NCT02588261
Adverse Events Module:
NCT02588261